Phaim Pharma Ltd
09355572
Some Concerns
- No accounts filed in last 18 months (-5)
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 15/12/2014
MEDICAL PRACTITIONER
BRITISH · UNITED KINGDOM · Age 50
Also on 5 other boards
director · Since 15/12/2014
MEDICAL PRACTITIONER
BRITISH · ENGLAND · Age 62
Also on 5 other boards
director · Since 15/12/2014
MEDICAL PRACTITIONER
HUNGARIAN,AMERICAN · UNITED KINGDOM · Age 74
director · Since 15/05/2019
EXECUTIVE DIRECTOR
BRITISH · ENGLAND · Age 61
Also on 4 other boards
director · Since 01/09/2022
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 69
Also on 2 other boards
Persons with Significant Control
Prof Piers Edward Francis Daubeney
British · England · Age 62
16, Great Queen Street, London, WC2B 5AH
Notified 06/04/2016
Dr Hiam Orban Nee Jalahey
Hungarian · England · Age 78
16, Great Queen Street, London, WC2B 5AH
Notified 06/04/2016
Dr Nara Daubeney
British · United Kingdom · Age 50
16, Great Queen Street, London, WC2B 5AH
Notified 06/04/2016
Dr Tihamer Orban
Hungarian · United Kingdom · Age 74
16, Great Queen Street, London, WC2B 5AH
Notified 06/04/2016
CompanyRankvs 23760+ SIC 72110 peers32
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
completion of pre-clinical tests and expressions of interest received to date, the directors have a valid expectation that sufficient funding can be secured. Accordingly, they continue to adopt the going concern assumption in the preparation of these financial statements. Nonetheless, the absence of firm commitments in respect of this capital does give rise to a material uncertainty which may ca
Key FinancialsYear ending 30/06/2024
Net Worth
-£791k
Balance sheet strength
Cash
£98
Cash in the bank
Net Current Assets
-£789k
Working capital
Current Assets
£69k
Current Liabilities
£858k
Fixed Assets
£1
Debtors
£69k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 0.08 | -£14k |
| 2023 | 0.16 | -£374k |
| 2022 | 0.39 | -£860k |
| 2021 | 5.42 | — |
Derived from filed accounts. Not audited figures.